DALLAS, Nov. 19, 2025 /PRNewswire/ — Dialectic Therapeutics, Inc., a clinical-stage biotechnology company developing innovative anti-cancer drugs, today announced that patient dosing is underway in a clinical trial led by the renowned Drs. Elizabeth Stover, Joyce […]
